ARTICLE | Clinical News
Trimesta: Completed Phase II enrollment
March 19, 2012 7:00 AM UTC
Synthetic Biologics (formerly Adeona Pharmaceuticals Inc.) completed enrollment of 164 patients in a double-blind, placebo-controlled, U.S. Phase II trial evaluating 8 mg Trimesta daily plus Copaxon...